Global disease score (GDS) is the name of the game!

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed.

1. Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [European journal of nuclear medicine and molecular imaging · 2026
   Article
2. [Molecular imaging and biology · 2025
   Article
3. Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.Annals of nuclear medicine · 2024
   Review
4. Current uses and understanding of PET imaging in cardiac sarcoidosis.American journal of nuclear medicine and molecular imaging · 2024
   Review
5. FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls.Diagnostics (Basel, Switzerland) · 2023
   Article
6. The role ofAnnals of nuclear medicine · 2023
   Review
7. Impact of [Diagnostics (Basel, Switzerland) · 2023
   Article
8. Common carotid segmentation inClinical physiology and functional imaging · 2023
   Article
9. The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19.European physical journal plus · 2023
   Review
10. "Global" cardiac atherosclerotic burden assessed by artificial intelligence-based versus manual segmentation inJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
11. FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.Scientific reports · 2022
    Article
12. Volumetric parameters from [Journal of neuroendocrinology · 2022
    Observational
13. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
14. PET-Based Imaging withDiagnostics (Basel, Switzerland) · 2021
    Review
15. Alavi-Carlsen Calcification Score (ACCS): A Simple Measure of Global Cardiac Atherosclerosis Burden.Diagnostics (Basel, Switzerland) · 2021
    Article
16. The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection.European journal of nuclear medicine and molecular imaging · 2021
    Article
17. Emerging role of 18F-FDG PET/CT in Castleman disease: a review.Insights into imaging · 2021
    Review
18. Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting.American journal of nuclear medicine and molecular imaging · 2021
    Review
19. European journal of hybrid imaging · 2020
    Article
20. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as